← Eichor
Study identifier: NCT06370000 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Oral Azacitidine in Transplant-Eligible Patients With Acute Myeloid Leukemia (AML) Suffering From Health-Inequality

Condition: Acute Myeloid Leukemia  ·  Sponsor: Virginia Commonwealth University

PhasePhase 4
Planned participants12
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Test feasibility of an oral maintenance strategy for transplant eligible AML patients in first CR who are medically underserved or have a disadvantage in the CDC SDOH domains

This description comes directly from the study's public registry record.

Talk to the study team

Massey IIT Research Operations  ·  804-628-6430  ·  masseyepd@vcu.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Virginia Commonwealth UniversityRichmond, Virginia, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06370000